Transcatheter aortic valve implantation (from inception to standard treatment): a single-center observational study
| Autor: | Martin Petter Høydahl, Rolf Busund, Assami Rösner, Didrik Kjønås |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Frontiers in Cardiovascular Medicine, Vol 11 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2297-055X 47596007 |
| DOI: | 10.3389/fcvm.2024.1298346 |
| Popis: | BackgroundTreatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI) was introduced in 2002. Since then, TAVI has become the primary treatment approach worldwide for advanced-age patients and younger patients with severe comorbidities. We aimed to evaluate the changes in patient demographics, complications, and mortality rates within 13 years.MethodsThis retrospective observational study included 867 patients who underwent TAVI at the University Hospital of North Norway in Tromsø from 2008 to 2021. The 13-year period was divided into period 1 (2008–2012), period 2 (2013–2017), and period 3 (2018–2021). The primary objective was to evaluate the changes in periprocedural (30 days), early (30–365 days), and late mortality rates (>365 days) between the periods. The secondary objective was to evaluate late mortality rates by sex and age groups: |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|